Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Free Cash Flow Generation Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Free Cash Flow Generation Index of -6.78x as of December 2024. Free cash flow of CN¥-163.10 Million represents -7% of operating cash flow (CN¥24.04 Million). Read Hunan Dajiaweikang Pharmaceutical Indust (301126) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. Explore Hunan Dajiaweikang Pharmaceutical Indust capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Free Cash Flow Generation Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full company profile including market capitalisation, see Hunan Dajiaweikang Pharmaceutical Indust stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.78x | CN¥-163.10 Million | CN¥24.04 Million | CN¥187.14 Million | ▲ +7.8% |
| 2023 | -7.36x | CN¥-199.57 Million | CN¥27.13 Million | CN¥226.70 Million | ▼ -1066.8% |
| 2019 | 0.76x | CN¥103.41 Million | CN¥135.91 Million | CN¥32.50 Million | — |